Fonterra completes sale of DFE Pharma
23 January 2020
FONTERRA COMPLETES SALE OF DFE PHARMA
Fonterra today announces that it has completed the sale of its 50% share of DFE Pharma to CVC
Strategic Opportunities II.
As previously announced in September 2019, this sale was subject to regulatory approvals from
competition authorities and these have now all been received.
Fonterra CFO, Marc Rivers, says the completion of this sale is a key milestone in strengthening the Co-
op’s balance sheet, with cash proceeds of $554 million, comprising of the original sale proceeds of $537
million plus $17 million in settlement adjustments.
Over the course of the 2020 financial year Fonterra expects there to be other one-off transactions as it
implements strategy and continues its asset portfolio review.
“It is too early to assess the overall impact of these on the Co-op’s 2020 financial year. The announced
forecast earnings range will continue to reflect just the underlying performance of the business. We will
provide details of the overall impact of all one-offs as part of our full-year financial statements and will also
provide an update as part of our Interim Results,” Mr Rivers says.
-ENDS-
For further information contact:
Fonterra Communications
24-hour media line
Phone: +64 21 507 072
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- FCG — Fonterra Co-operative Group Limited: Fonterra completes sale of DFE Pharma2020-01-22
“23 January 2020 FONTERRA COMPLETES SALE OF DFE PHARMA Fonterra today announces that it has completed the sale of its 50% share of DFE Pharma to CVC Strategic Opportunities II. As previously announced in September 2019, this sale was subject to regulatory approvals from…”
- FCG — Fonterra Co-operative Group Limited: Fonterra reports its Interim Results2020-03-17
“Notes to the Financial Statements CONTINUED FOR THE SIX MONTHS ENDED 31 JANUARY 2020 2 STRATEGY REVIEW UPDATE During the year ended 31 July 2019 Fonterra announced and began the implementation of a Group-wide strategy review. This note explains the accounting impact of the…”
- FCG — Fonterra Co-operative Group Limited: Fonterra Shareholders’ Fund Interim Results 20202020-03-17
“Page 1 Results for announcement to the market Name of issuer Fonterra Shareholders’ Fund Reporting Period 6 months to 31 January 2020 Previous Reporting Period 6 months to 31 January 2019 Currency New Zealand Dollars Amount (m’s) Percentage change Revenue from contin…”